These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
2 files

Atropselective Disposition of 2,2',3,4',6-Pentachlorobiphenyl (PCB 91) and Identification of Its Metabolites in Mice with Liver-specific Deletion of Cytochrome P450 Reductase

submitted on 03.06.2019, 20:57 and posted on 04.06.2019, 15:56 by Xianai Wu, Guangshu Zhai, Jerald L. Schnoor, Hans-Joachim Lehmler
Cytochrome P450 enzymes oxidize chiral polychlorinated biphenyls (PCBs) to hydroxylated metabolites. Here we investigated the role of an impaired hepatic metabolism in the disposition of PCB 91 (CASRN 68194-05-8) in mice with a liver-specific deletion of the cpr gene (KO mice). KO mice and wild type (WT) mice were exposed to racemic PCB 91. Levels and enantiomeric fractions of PCB 91 and its metabolites were determined in tissues 3-days after PCB exposure. PCB 91 were higher in KO compared to WT mice. The liver of KO mice accumulated PCB 91 due to the high fat content in the liver of KO mice. 2,2',3,4',6-Pentachlorobiphenyl-5-ol was the major metabolite detected in all samples. PCB 91 and its metabolites displayed a genotype-dependent atropisomeric enrichment. These differences in atropselective disposition of PCB 91 and its metabolites are consistent with slower metabolism of PCB 91 in KO than WT mice and the accumulation of the parent PCB in the fatty liver of KO mice.






Email Address of Submitting Author


University of Iowa



ORCID For Submitting Author


Declaration of Conflict of Interest

Nothing to declare